576 related articles for article (PubMed ID: 10672132)
41. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission.
Valentini L; Schaper L; Buning C; Hengstermann S; Koernicke T; Tillinger W; Guglielmi FW; Norman K; Buhner S; Ockenga J; Pirlich M; Lochs H
Nutrition; 2008; 24(7-8):694-702. PubMed ID: 18499398
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of bone mineral density among patients with inflammatory bowel disease in a tertiary care setting in India.
Khadgawat R; Makharia GK; Puri K
Indian J Gastroenterol; 2008; 27(3):103-6. PubMed ID: 18787279
[TBL] [Abstract][Full Text] [Related]
43. Comparison of the possible risk factors of bone mineral density in subjects with ulcerative colitis and healthy subjects.
Kaya G; Koçak E; Akbal E; Taş A; Köklü S
South Med J; 2011 Nov; 104(11):747-51. PubMed ID: 22024784
[TBL] [Abstract][Full Text] [Related]
44. Risk Factors for Low Bone Density in Inflammatory Bowel Disease: Use of Glucocorticoids, Low Body Mass Index, and Smoking.
Even Dar R; Mazor Y; Karban A; Ish-Shalom S; Segal E
Dig Dis; 2019; 37(4):284-290. PubMed ID: 30799399
[TBL] [Abstract][Full Text] [Related]
45. High prevalence of morphometric vertebral deformities in patients with inflammatory bowel disease.
Heijckmann AC; Huijberts MS; Schoon EJ; Geusens P; de Vries J; Menheere PP; van der Veer E; Wolffenbuttel BH; Stockbrugger RW; Dumitrescu B; Nieuwenhuijzen Kruseman AC
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):740-7. PubMed ID: 18617778
[TBL] [Abstract][Full Text] [Related]
46. Assessment of bone and mineral metabolism in inflammatory bowel disease: case series and review.
Sinnott BP; Licata AA
Endocr Pract; 2006; 12(6):622-9. PubMed ID: 17229657
[TBL] [Abstract][Full Text] [Related]
47. Sex hormone status and bone metabolism in men with Crohn's disease.
Robinson RJ; Iqbal SJ; Al-Azzawi F; Abrams K; Mayberry JF
Aliment Pharmacol Ther; 1998 Jan; 12(1):21-5. PubMed ID: 9692696
[TBL] [Abstract][Full Text] [Related]
48. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
Jehle PM; Jehle DR; Mohan S; Böhm BO
J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
[TBL] [Abstract][Full Text] [Related]
49. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
[TBL] [Abstract][Full Text] [Related]
50. Biochemical parameters associated with low bone density in healthy men and women.
Sherman SS; Tobin JD; Hollis BW; Gundberg CM; Roy TA; Plato CC
J Bone Miner Res; 1992 Oct; 7(10):1123-30. PubMed ID: 1456082
[TBL] [Abstract][Full Text] [Related]
51. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease.
Boot AM; Bouquet J; Krenning EP; de Muinck Keizer-Schrama SM
Gut; 1998 Feb; 42(2):188-94. PubMed ID: 9536942
[TBL] [Abstract][Full Text] [Related]
52. Alert for bone alterations and low serum concentrations of vitamin D in patients with intestinal inflammatory disease.
Kotze LM; Costa CT; Cavassani MF; Nisihara RM
Rev Assoc Med Bras (1992); 2017 Jan; 63(1):13-17. PubMed ID: 28225873
[TBL] [Abstract][Full Text] [Related]
53. Serum adipokines in inflammatory bowel disease.
Waluga M; Hartleb M; Boryczka G; Kukla M; Zwirska-Korczala K
World J Gastroenterol; 2014 Jun; 20(22):6912-7. PubMed ID: 24944482
[TBL] [Abstract][Full Text] [Related]
54. [Low levels of 25-hydroxyvitamin D (25OHD) in patients with inflammatory bowel disease and its correlation with bone mineral density].
Souza HN; Lora FL; Kulak CA; Mañas NC; Amarante HM; Borba VZ
Arq Bras Endocrinol Metabol; 2008 Jun; 52(4):684-91. PubMed ID: 18604382
[TBL] [Abstract][Full Text] [Related]
55. Nutritional markers, not markers of bone turnover, are related predictors of bone mineral density in chronic peritoneal dialysis patients.
Jeong JU; Lee HK; Kim YJ; Kim JS; Kang SS; Kim SB
Clin Nephrol; 2010 Nov; 74(5):336-42. PubMed ID: 20979940
[TBL] [Abstract][Full Text] [Related]
56. Bone Metabolism and the c.-223C > T Polymorphism in the 5'UTR Region of the Osteoprotegerin Gene in Patients with Inflammatory Bowel Disease.
Krela-Kaźmierczak I; Kaczmarek-Ryś M; Szymczak A; Michalak M; Skrzypczak-Zielińska M; Drwęska-Matelska N; Marcinkowska M; Eder P; Łykowska-Szuber L; Wysocka E; Linke K; Słomski R
Calcif Tissue Int; 2016 Dec; 99(6):616-624. PubMed ID: 27639566
[TBL] [Abstract][Full Text] [Related]
57. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study.
Jahnsen J; Falch JA; Aadland E; Mowinckel P
Gut; 1997 Mar; 40(3):313-9. PubMed ID: 9135518
[TBL] [Abstract][Full Text] [Related]
58. Osteopenia and osteoporosis in Crohn's disease: prevalence in a Dutch population-based cohort.
Schoon EJ; van Nunen AB; Wouters RS; Stockbrügger RW; Russel MG
Scand J Gastroenterol Suppl; 2000; (232):43-7. PubMed ID: 11232491
[TBL] [Abstract][Full Text] [Related]
59. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry.
Bokemeyer B; Hardt J; Hüppe D; Prenzler A; Conrad S; Düffelmeyer M; Hartmann P; Hoffstadt M; Klugmann T; Schmidt C; Weismüller J; Mittendorf T; Raspe H
J Crohns Colitis; 2013 Jun; 7(5):355-68. PubMed ID: 22503168
[TBL] [Abstract][Full Text] [Related]
60. Vitamin D Status and Bone Mineral Density in Children with Inflammatory Bowel Disease Compared to Those with Functional Abdominal Pain.
Sohn J; Chang EJ; Yang HR
J Korean Med Sci; 2017 Jun; 32(6):961-967. PubMed ID: 28480654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
